← Back to guidelines
Infectious Disease63 papers

Tuberculosis of breast

Last edited: 4/10/2026

Overview

Tuberculosis (TB) of the breast is a rare form of extrapulmonary tuberculosis that may mimic breast malignancy clinically and radiologically. Patients with a history of tuberculosis demonstrate an increased risk of developing subsequent malignancies, necessitating careful diagnostic differentiation between chronic infection and neoplasia 1.

Diagnosis

  • Clinical presentation often overlaps with breast carcinoma, requiring high clinical suspicion in endemic regions 1.
  • Diagnostic evaluation should prioritize the exclusion of malignancy, as the pooled standardized incidence ratio (SIR) for all cancers is significantly elevated (SIR 1.62) in individuals with a history of TB 1.
  • The risk of malignancy is highest within the first year following a TB diagnosis (SIR 4.70), suggesting that persistent breast masses in this timeframe require rigorous investigation 1.
  • Special Populations

  • Individuals with a history of TB are at a significantly higher risk for developing lung cancer (SIR 3.20) compared to the general population 1.
  • The elevated risk of malignancy persists across the TB-affected population, with the highest incidence observed in the 12 months immediately following the initial TB diagnosis 1.
  • Key Recommendations

  • Clinicians should maintain a high index of suspicion for malignancy in patients with a history of TB, particularly when presenting with breast masses within the first year of TB diagnosis 1. (Evidence: Moderate)
  • References

    1 Luczynski P, Poulin P, Romanowski K, Johnston JC. Tuberculosis and risk of cancer: A systematic review and meta-analysis. PloS one 2022. link

    Original source

    1. [1]
      Tuberculosis and risk of cancer: A systematic review and meta-analysis.Luczynski P, Poulin P, Romanowski K, Johnston JC PloS one (2022)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG